| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.5M | — | -40.7% |
| SG&A Expense | $3.1M | — | -6.4% |
| Operating Income | -$6.5M | — | +28.4% |
| Pre-tax Income | -$7.3M | — | +23.9% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$7.3M | +2.8% | +13.4% |
| EPS (Basic) | -$0.13 | — | +38.1% |
| EPS (Diluted) | -$0.13 | — | +38.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $21.7M | -18.9% | -45.8% |
| Current Assets | $22.9M | -19.0% | -46.1% |
| Total Assets | $24.7M | -19.1% | -47.6% |
| Current Liabilities | $10.1M | +7.0% | -44.4% |
| Total Liabilities | $20.8M | -2.2% | -15.8% |
| Stockholders' Equity | $3.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | +51.6% |
| Financing Cash Flow | -$680K | — | -109.3% |
| -82.6% |